Shocked by FDA inaction
20:08–20:46 · 38s
Schrag says he expected the FDA to halt Cassava’s drug within days but was stunned by the agency’s limited response, leading him to uncover broader misconduct.
20:08–20:46 · 38s
Schrag says he expected the FDA to halt Cassava’s drug within days but was stunned by the agency’s limited response, leading him to uncover broader misconduct.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.